Arkolith/Insider Trading/SLDB/Form 4

Hanrahan Jessie

Chief Regulatory OfficerSolid Biosciences Inc. (SLDB) · full profile →Form 4 · filed Feb 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$171K
Net Open-Market Flow
-$171K
Transactions
7
3 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2026Sell(S)27K$6.44$171K83K
Jan 31, 2026Option exercise(M)28K——109K
Jan 29, 2026Option exercise(M)55K——82K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2026Option exercise(M)28K—$083K
Jan 29, 2026Option exercise(M)55K—$00
Jan 29, 2026Grant(A)95K—$095K
Jan 29, 2026Grant(A)190K—$0190K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-034085) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML